Publications by authors named "L Dominici"
Nodal disease burden and oncologic outcomes of 312 real-world patients with HR+HER2-breast cancer meeting SOUND eligibility criteria were similar to the SLNB arm of the SOUND trial, supporting careful implementation of omission of SLNB in this population ( https://doi.org/ https://doi.org/10.
View Article and Find Full Text PDFArticle Synopsis
- The SOUND trial found that for early-stage breast cancer patients with negative axillary ultrasound, skipping sentinel lymph node biopsy (SLNB) is just as effective as traditional axillary staging.
- This study analyzed a group of patients with hormone receptor-positive (HR+) HER2-negative breast cancer, confirming that their outcomes and disease characteristics align with the SOUND trial's findings.
- Results showed that very few patients had positive lymph nodes, no axillary recurrences were noted in the follow-up, and for postmenopausal women, SLNB omission didn't change chemotherapy recommendations, indicating safe application of the trial's conclusions in real-world settings.
Article Synopsis
- Fungal conservation is increasingly important but faces challenges like a lack of data on diversity, population sizes, and extinction risks due to fungi's vast diversity and complex taxonomy.
- The paper discusses how citizen science (CS) can be effectively utilized to gather data on fungal diversity through various engaging projects, including broad collecting schemes and targeted sampling methods.
- It emphasizes the need for collaboration between professional mycologists and local communities to enhance data collection, broaden participation, and turn findings into practical conservation efforts.
Background: Stereotactic ablative radiotherapy (SABR) is emerging as a potential local treatment option for oligometastatic RCC. This study aims to evaluate the efficacy of SABR in patients with oligorecurrent RCC.
Methods: A total of 50 patients with histologically confirmed RCC underwent SABR for oligorecurrence between 2006 and 2022.